Does AMISULPRIDE Cause Agranulocytosis? 16 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Agranulocytosis have been filed in association with AMISULPRIDE (Barhemsys). This represents 0.5% of all adverse event reports for AMISULPRIDE.
16
Reports of Agranulocytosis with AMISULPRIDE
0.5%
of all AMISULPRIDE reports
0
Deaths
16
Hospitalizations
How Dangerous Is Agranulocytosis From AMISULPRIDE?
Of the 16 reports, 16 (100.0%) required hospitalization, and 2 (12.5%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
Yes, Agranulocytosis is listed as a known adverse reaction in the official FDA drug label for AMISULPRIDE.
What Other Side Effects Does AMISULPRIDE Cause?
Drug ineffective (665)
Weight increased (346)
Toxicity to various agents (305)
Suicide attempt (261)
Akathisia (252)
Extrapyramidal disorder (226)
Drug abuse (219)
Leukopenia (218)
Therapeutic product effect incomplete (200)
Off label use (191)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which AMISULPRIDE Alternatives Have Lower Agranulocytosis Risk?
AMISULPRIDE vs AMITRIPTYLINE
AMISULPRIDE vs AMITRIPTYLINE\PERPHENAZINE
AMISULPRIDE vs AMIVANTAMAB
AMISULPRIDE vs AMIVANTAMAB-VMJW
AMISULPRIDE vs AMLODIPINE